Erin Calipari

Director, Vanderbilt Center for Addiction Research
Associate professor of pharmacology, Vanderbilt University

Erin Calipari is director of the Vanderbilt Center for Addiction Research and associate professor of pharmacology at Vanderbilt University. She is a neuroscientist whose work focuses on understanding how the brain’s reward and motivation systems adapt to experience, and how these processes become dysregulated in addiction.

As director of the Vanderbilt Center for Addiction Research, Calipari leads a multidisciplinary group of faculty, trainees and staff working to identify the biological, environmental and developmental factors that confer risk for addiction. Under her leadership, the center also engages in targeted outreach to inform and empower communities through evidence-based education on the science of addiction.

Calipari earned her Ph.D. in neuroscience at Wake Forest University School of Medicine, where she studied how drugs of abuse alter dopaminergic signaling to shape addictive behaviors. She then completed her postdoctoral training at the Icahn School of Medicine at Mount Sinai, using advanced genetic and molecular approaches to investigate how drugs remodel brain circuits and influence behavior. Across her career, she has integrated behavioral, circuit-level, microcircuit and molecular techniques to uncover the mechanisms that govern adaptive and maladaptive learning. Her work has led to more than 100 publications and numerous honors, including the Presidential Early Career Award for Scientists and Engineers from the White House.

Explore more from The Transmitter

Trading places: What happens when neuroscience turns into machine learning, and machine learning turns into neuroscience?

Neuroscience has become increasingly concerned with prediction, and machine learning with causal explanation, with each field adopting methods from the other. I asked eight experts to weigh in on what we stand to learn from this exchange.

By Samuel Gershman
23 March 2026 | 22 min read
DNA strand

Exon-skipping approach boosts levels of key Rett syndrome protein

Deleting a small region of the MECP2 gene partially restored function in neurons derived from people with Rett-associated variants.

By Giorgia Guglielmi
20 March 2026 | 5 min read
Collage with a portrait of Caitlin Vander Weele in the foreground.

Frameshift: How Caitlin Vander Weele made science communication her business

Her favorite part of research was talking about it. So she left academia and turned that passion into a successful company.

By Katie Moisse
19 March 2026 | 6 min read